Green and Hill Industries, Inc Stock price Other OTC
Equities
GHIL
US39260U1060
Pharmaceuticals
Financials (USD)
Sales 2013 | - | Sales 2014 | 0 | Capitalization | 103 |
---|---|---|---|---|---|
Net income 2013 | - | Net income 2014 | - | EV / Sales 2013 * | - |
Net cash position 2013 * | - | Net cash position 2014 * | - | EV / Sales 2014 * | - |
P/E ratio 2013 * |
-
| P/E ratio 2014 * |
-
| Employees | - |
Yield 2013 * |
-
| Yield 2014 * |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Rebagliati
CEO | Chief Executive Officer | - | 14-03-16 |
Patrick Smyth
PSD | President | - | 14-03-16 |
Lorne Green
SEC | Corporate Secretary | - | 13-01-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Smyth
PSD | President | - | 14-03-16 |
Lorne Green
SEC | Corporate Secretary | - | 13-01-11 |
Ross Rebagliati
CEO | Chief Executive Officer | - | 14-03-16 |
1st Jan change | Capi. | |
---|---|---|
+22.71% | 5.39B | |
-12.40% | 4.67B | |
-5.99% | 3.29B | |
-17.15% | 2.6B | |
-3.06% | 2.52B | |
-6.78% | 1.7B | |
+22.27% | 1.63B | |
-8.49% | 1.61B | |
-5.38% | 1.56B |